Pneumatic Nebulizer Market worth over $789.9mn by 2027

Pneumatic Nebulizer Market size is set to surpass USD 789.9 million by 2027, according to a new research report by Global Market Insights Inc.
 

The increasing prevalence of respiratory diseases and technological advancements in developed economies will propel the market growth. There has been an increased prevalence of community-acquired pneumonia (CAP). For instance, annually community-acquired pneumonia is responsible for 3 million deaths worldwide. The deadly infection mutates at a fast rate and is considered a multidrug-resistant (MDR) microorganism. The prevalence of CAP varies from country to country owing to the rate to spread of infection among the population.
 

Increasing prevalence of chronic obstructive pulmonary disease (COPD) will foster the market expansion

The prevalence of chronic obstructive pulmonary disease (COPD) has exponentially increased over the past decade and it is one of leading cause of death worldwide. According to the WHO, 3.23 million deaths occurred in 2019 due to COPD. Significant prevalence is attributed to the rising consumption of tobacco or cigarettes, inhalation of occupational smoke, fume or chemicals, and rising air pollution. Various strategies have been employed, such as the WHO Global Action Plan for the Prevention and Control of Noncommunicable Diseases (NCDs) includes COPD to raise awareness regarding the disease. Through initiatives, the diagnosis and treatment associated with COPD will extend. The prescribed treatment of COPD includes inhalation therapy, medication administrated via nebulizers, thereby, accelerating the demand for market.
 

Availability of alternative devices may slow down the pneumatic nebulizer market progression

Availability of other aerosol medication inhalers such as dry powder inhalers (DPIs), metered-dose inhalers (MDIs), and soft mist inhalers (SMIs) may slow down the industry growth of pneumatic nebulizers. These new inhalers are user-friendly and administer consistent and accurate medication from the device. Nebulization generates high output, resulting in wastage of drug. Technological advancements in aerosol therapies might hinder the market revenue of pneumatic nebulizers. Moreover, the high price of pneumatic nebulizers may shift customer preference from nebulizers to inhalers.
 

Browse key industry insights spread across 110 pages with 150 market data tables & 9 figures & charts from the report, “Pneumatic Nebulizer Market Size By Product (Vented {Tabletop, Portable}, Breath-Actuated {Tabletop, Portable}), COVID-19 Impact Analysis, Regional Outlook, Product Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027” in detail along with the table of contents:
https://www.gminsights.com/industry-analysis/pneumatic-nebulizers-market
 

Spread of respiratory infection will spur the segment growth

The vented segment captured 39.4% of the pneumatic nebulizer market share in 2020. An increase in the prevalence of asthma, COPD, and other respiratory disorders will lead to segment expansion. Numerous respiratory infection has arisen like coronavirus, swine flu (H1N1), avian Flu H5N1 (bird flu), enterovirus, influenza, pneumonia, and others. This will lead to higher adoption of pneumatic nebulizers for the treatment of infection, thereby stimulating the pneumatic nebulizers product demand in the industry.
 

Prevalence of respiratory disease in the European region has enhanced the market value

Europe pneumatic nebulizer market size will reach USD 245.2 million by 2027. According to a report published by European Union states that the leading cause of death among the European population is due to respiratory diseases. Deaths are associated with diseases like asthma, pneumonia, or chronic obstructive pulmonary disease. Technological advancement allows innovative approaches in the treatment of respiratory diseases. Furthermore, the pneumatic nebulizers upgraded over the last decade which is user friendly and easy to operate that will influence the industry expansion.
 

Companies are focusing on launching various pneumatic nebulizers product to boost the industry revenue

Prominent companies functioning in the pneumatic nebulizer market are Aerogen Limited, Allied Healthcare Products, Inc., Briggs Healthcare, Becton, Dickinson and Company, Heyer Medical AG, OMRON Corporation, PARI Medical Holdings GmbH, Philips Respironics, Inc., Salter Labs and TaiDoc Technology. The market leaders undertake various strategic initiatives to gain a competitive edge in the industry.